White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure

References

1. 1.↵
   1. Sirnes E,
   2. Elgen IB,
   3. Chong WK, et al

   . Cerebral magnetic resonance imaging in children with prenatal drug exposure. Clin Pediatr (Phila) 2017;56:326–32 doi:10.1177/0009922816657154 pmid:27356632

   CrossRefPubMed
2. 2.↵
   1. Kahila H,
   2. Kivitie-Kallio S,
   3. Halmesmäki E, et al

   . Brain magnetic resonance imaging of infants exposed prenatally to buprenorphine. Acta Radiol 2007;48:228–31 doi:10.1080/02841850601100875 pmid:17354146

   CrossRefPubMed
3. 3.↵
   1. Towers CV,
   2. Hyatt BW,
   3. Visconti KC, et al

   . Neonatal head circumference in newborns with neonatal abstinence syndrome. Pediatrics 2019;143:e20180541 doi:10.1542/peds.2018-0541 pmid:30530638

   Abstract/FREE Full Text
4. 4.↵
   1. Sirnes E,
   2. Oltedal L,
   3. Bartsch H, et al

   . Brain morphology in school-aged children with prenatal opioid exposure: a structural MRI study. Early Hum Dev 2017;106-107:33–39 doi:10.1016/j.earlhumdev.2017.01.009 pmid:28187337

   CrossRefPubMed
5. 5.↵
   1. Nygaard E,
   2. Slinning K,
   3. Moe V, et al

   . Neuroanatomical characteristics of youths with prenatal opioid and poly-drug exposure. Neurotoxicol Teratol 2018;68:13–26 doi:10.1016/j.ntt.2018.04.004 pmid:29679636

   CrossRefPubMed
6. 6.↵
   1. Monnelly VJ,
   2. Anblagan D,
   3. Quigley A, et al

   . Prenatal methadone exposure is associated with altered neonatal brain development. Neuroimage Clin 2018;18:9–14 doi:10.1016/j.nicl.2017.12.033 pmid:29326869

   CrossRefPubMed
7. 7.↵
   1. Chisolm MS,
   2. Fitzsimons H,
   3. Leoutsakos JM, et al

   . A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res 2013;15:1297–1304 doi:10.1093/ntr/nts274 pmid:23288871

   CrossRefPubMed
8. 8.↵
   1. Epstein RL,
   2. Sabharwal V,
   3. Wachman EM, et al

   . Perinatal transmission of hepatitis C virus: defining the cascade of care. J Pediatr 2018;203:34–40.e31 doi:10.1016/j.jpeds.2018.07.006 pmid:30170857

   CrossRefPubMed
9. 9.↵
   1. Ekblad M,
   2. Korkeila J,
   3. Lehtonen L.

   Smoking during pregnancy affects foetal brain development. Acta Paediatr 2015;104:12–18 doi:10.1111/apa.12791 pmid:25169748

   CrossRefPubMed
10. 10.↵
    1. El Marroun H,
    2. Schmidt MN,
    3. Franken IH, et al

    . Prenatal tobacco exposure and brain morphology: a prospective study in young children. Neuropsychopharmacol 2014;39:792–800 doi:10.1038/npp.2013.273 pmid:24096296

    CrossRefPubMed
11. 11.↵
    1. Roza SJ,
    2. Verburg BO,
    3. Jaddoe VW, et al

    . Effects of maternal smoking in pregnancy on prenatal brain development: the Generation R Study. Eur J Neurosci 2007;25:611–17 doi:10.1111/j.1460-9568.2007.05393.x pmid:17298594

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Anblagan D,
    2. Jones NW,
    3. Costigan C, et al

    . Maternal smoking during pregnancy and fetal organ growth: a magnetic resonance imaging study. PLoS One 2013;8:e67223 doi:10.1371/journal.pone.0067223 pmid:23843995

    CrossRefPubMed
13. 13.↵
    1. Bladowska J,
    2. Zimny A,
    3. Knysz B, et al

    . Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. J Hepatol 2013;59:651–57 doi:10.1016/j.jhep.2013.05.008 pmid:23680314

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Kidokoro H,
    2. Neil JJ,
    3. Inder TE.

    New MR imaging assessment tool to define brain abnormalities in very preterm infants at term. AJNR Am J Neuroradiol 2013;34:2208–14 doi:10.3174/ajnr.A3521 pmid:23620070

    Abstract/FREE Full Text
15. 15.↵
    1. Back SA.

    White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol 2017;134:331–49 doi:10.1007/s00401-017-1718-6 pmid:28534077

    CrossRefPubMed
16. 16.↵
    1. Volpe JJ.

    Confusions in nomenclature: “periventricular leukomalacia” and “white matter injury”-identical, distinct, or overlapping? Pediatr Neurol 2017;73:3–6 doi:10.1016/j.pediatrneurol.2017.05.013 pmid:28648484

    CrossRefPubMed
17. 17.↵
    1. Hayman M,
    2. van Wezel-Meijler G,
    3. van Straaten H, et al

    . Punctate white-matter lesions in the full-term newborn: underlying aetiology and outcome. Eur J Paediatr Neurol 2019;23:280–87 doi:10.1016/j.ejpn.2019.01.005 pmid:30744982

    CrossRefPubMed
18. 18.↵
    1. Marelli A,
    2. Miller SP,
    3. Marino BS, et al

    . Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation 2016;133:1951–62 doi:10.1161/CIRCULATIONAHA.115.019881 pmid:27185022

    Abstract/FREE Full Text
19. 19.↵
    1. Guo T,
    2. Chau V,
    3. Peyvandi S, et al

    . White matter injury in term neonates with congenital heart diseases: topology and comparison with preterm newborns. Neuroimage 2019;185:742–49 doi:10.1016/j.neuroimage.2018.06.004 pmid:29890324

    CrossRefPubMed
20. 20.↵
    1. Cornette LG,
    2. Tanner SF,
    3. Ramenghi LA, et al

    . Magnetic resonance imaging of the infant brain: anatomical characteristics and clinical significance of punctate lesions. Arch Dis Child Fetal Neonatal Ed 2002;86:F171–77 doi:10.1136/fn.86.3.F171 pmid:11978747

    Abstract/FREE Full Text
21. 21.↵
    1. Tusor N,
    2. Benders MJ,
    3. Counsell SJ, et al

    . Punctate white matter lesions associated with altered brain development and adverse motor outcome in preterm infants. Sci Rep 2017;7:13250 doi:10.1038/s41598-017-13753-x pmid:29038505

    CrossRefPubMed
22. 22.↵
    1. Parikh NA,
    2. Pierson CR,
    3. Rusin JA.

    Neuropathology associated with diffuse excessive high signal intensity abnormalities on magnetic resonance imaging in very preterm infants. Pediatr Neurol 2016;65:78–85 doi:10.1016/j.pediatrneurol.2016.07.006 pmid:27567289

    CrossRefPubMed
23. 23.↵
    1. de Bruïne FT,
    2. van den Berg-Huysmans AA,
    3. Leijser LM, et al

    . Clinical implications of MR imaging findings in the white matter in very preterm infants: a 2-year follow-up study. Radiology 2011;261:899–906 doi:10.1148/radiol.11110797 pmid:22031710

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Jeon TY,
    2. Kim JH,
    3. Yoo SY, et al

    . Neurodevelopmental outcomes in preterm infants: comparison of infants with and without diffuse excessive high signal intensity on MR images at near-term-equivalent age. Radiology 2012;263:518–26 doi:10.1148/radiol.12111615 pmid:22403166

    CrossRefPubMed
25. 25.↵
    1. Broström L,
    2. Bolk J,
    3. Padilla N, et al

    . Clinical implications of diffuse excessive high signal intensity (DEHSI) on neonatal MRI in school age children born extremely preterm. PLoS One 2016;11:e0149578 doi:10.1371/journal.pone.0149578 pmid:26886451

    CrossRefPubMed
26. 26.↵
    1. Parikh NA,
    2. He L,
    3. Bonfante-Mejia E, et al

    . Automatically quantified diffuse excessive high signal intensity on MRI predicts cognitive development in preterm infants. Pediatr Neurol 2013;49:424–30 doi:10.1016/j.pediatrneurol.2013.08.026 pmid:24138952

    CrossRefPubMed
27. 27.↵
    1. Mürner-Lavanchy IM,
    2. Kidokoro H,
    3. Thompson DK, et al

    . Thirteen-year outcomes in very preterm children associated with diffuse excessive high signal intensity on neonatal magnetic resonance imaging. J Pediatr 2019;206:66–71.e61 doi:10.1016/j.jpeds.2018.10.016 pmid:30414629

    CrossRefPubMed
28. 28.↵
    1. Hahn JS,
    2. Barnes PD,
    3. Clegg NJ, et al

    . Septopreoptic holoprosencephaly: a mild subtype associated with midline craniofacial anomalies. AJNR Am J Neuroradiol 2010;31:1596–1601 doi:10.3174/ajnr.A2123 pmid:20488907

    Abstract/FREE Full Text
29. 29.↵
    1. Dubourg C,
    2. Bendavid C,
    3. Pasquier L, et al

    . Holoprosencephaly. Orphanet J Rare Dis 2007;2:8 doi:10.1186/1750-1172-2-8 pmid:17274816

    CrossRefPubMed
30. 30.↵
    1. Johnson CY,
    2. Rasmussen SA.

    Non-genetic risk factors for holoprosencephaly. Am J Med Genet C Semin Med Genet 2010;154C:73–85 doi:10.1002/ajmg.c.30242 pmid:20104598

    CrossRefPubMed
31. 31.↵
    1. Yuan Q,
    2. Rubic M,
    3. Seah J, et al

    . Do maternal opioids reduce neonatal regional brain volumes? A pilot study. J Perinatol 2014;34:909–13 doi:10.1038/jp.2014.111 pmid:24945162

    CrossRefPubMed
32. 32.↵
    1. Walhovd KB,
    2. Moe V,
    3. Slinning K, et al

    . Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 2007;36:1331–44 doi:10.1016/j.neuroimage.2007.03.070 pmid:17513131

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Walhovd KB,
    2. Watts R,
    3. Amlien I, et al

    . Neural tract development of infants born to methadone-maintained mothers. Pediatr Neurol 2012;47:1–6 doi:10.1016/j.pediatrneurol.2012.04.008 pmid:22704008

    CrossRefPubMed
34. 34.↵
    1. Walhovd KB,
    2. Westlye LT,
    3. Moe V, et al

    . White matter characteristics and cognition in prenatally opiate- and polysubstance-exposed children: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2010;31:894–900 doi:10.3174/ajnr.A1957 pmid:20203117

    Abstract/FREE Full Text
35. 35.↵
    1. Robinson SE,
    2. Maher JR,
    3. Wallace MJ, et al

    . Perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the weanling rat. Neurotoxicol Teratol 1997;19:295–303 doi:10.1016/S0892-0362(97)00018-4 pmid:9253008

    CrossRefPubMed
36. 36.↵
    1. Wu VW,
    2. Mo Q,
    3. Yabe T, et al

    . Perinatal opioids reduce striatal nerve growth factor content in rat striatum. Eur J Pharmacol 2001;414:211–14 doi:10.1016/S0014-2999(01)00807-X pmid:11239921

    CrossRefPubMed
37. 37.↵
    1. Wu CC,
    2. Hung CJ,
    3. Shen CH, et al

    . Prenatal buprenorphine exposure decreases neurogenesis in rats. Toxicol Lett 2014;225:92–101 doi:10.1016/j.toxlet.2013.12.001 pmid:24321744

    CrossRefPubMed
38. 38.↵
    1. Vestal-Laborde AA,
    2. Eschenroeder AC,
    3. Bigbee JW, et al

    . The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination. Dev Neurosci 2014;36:409–21 doi:10.1159/000365074 pmid:25138998

    CrossRefPubMed
39. 39.↵
    1. Sanchez ES,
    2. Bigbee JW,
    3. Fobbs W, et al

    . Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 2008;56:1017–27 doi:10.1002/glia.20675 pmid:18381654

    CrossRefPubMed
40. 40.↵
    1. Toro R,
    2. Leonard G,
    3. Lerner JV, et al

    . Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacol 2008;33:1019–27 doi:10.1038/sj.npp.1301484 pmid:17609681

    CrossRefPubMedWeb of Science